Literature DB >> 8178625

Neurological and neuropsychiatric dysfunction in primary Sjögren's syndrome.

E Mauch1, C Völk, G Kratzsch, H Krapf, H H Kornhuber, H Laufen, K J Hummel.   

Abstract

In a prospective clinical investigation of 20 patients with primary Sjögren's syndrome (SS), neurological complications, not attributable to other diseases were detected in 14 patients (= 70%). Dysfunction of the peripheral nervous system (PNS) was nearly twice as frequent as central nervous system (CNS) complications. PNS involvement was dominated by symmetric sensory neuropathies, carpal tunnel syndromes, cranial nerve palsies (above all trigeminal sensory neuropathy) and pupillary dysfunction. CNS impairment was represented by cortical atrophy (n = 4), hemiparesis (n = 1) and aseptic meningitis (n = 1). Though CNS complications were rare, psychometric testing revealed diminished cognitive capacity in 14 patients. In addition to the characteristic sicca syndrome patients suffered from musculoskeletal pain and recurring abnormal sensation which frequently lead to the misdiagnosis of functional disorders. Additionally the frequent occurrence of psychiatric symptoms such as nervosity and depression support the impression of a psychosomatic pattern with no organic basis.

Entities:  

Mesh:

Year:  1994        PMID: 8178625

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  23 in total

Review 1.  CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.

Authors:  M Govoni; M Padovan; N Rizzo; F Trotta
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Central nervous system involvement in Sjogren's syndrome.

Authors:  F C Soliotis; C P Mavragani; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

3.  Recurrent aseptic meningitis: a new CSF complication of Sjogren's syndrome.

Authors:  Kazuyuki Ishida; Toshiki Uchihara; Hidehiro Mizusawa
Journal:  J Neurol       Date:  2007-04-09       Impact factor: 4.849

4.  Cerebellar degeneration in primary Sjӧgren syndrome.

Authors:  Mohammad Heidary; Samira Alesaeidi; Khashayar Afshari
Journal:  BMJ Case Rep       Date:  2018-06-06

5.  Primary Sjogren's syndrome: cognitive symptoms, mood, and cognitive performance.

Authors:  B M Segal; B Pogatchnik; E Holker; H Liu; J Sloan; N Rhodus; K L Moser
Journal:  Acta Neurol Scand       Date:  2011-06-09       Impact factor: 3.209

6.  Characterization of cognitive dysfunction in Sjögren's syndrome patients.

Authors:  Lynn C Epstein; Gina Masse; Jerold S Harmatz; Tammy M Scott; Athena S Papas; David J Greenblatt
Journal:  Clin Rheumatol       Date:  2013-12-15       Impact factor: 2.980

7.  Involvement of the peripheral nervous system in primary Sjögren's syndrome.

Authors:  P J Barendregt; M J van den Bent; V J van Raaij-van den Aarssen; A H van den Meiracker; C J Vecht; G L van der Heijde; H M Markusse
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

8.  Psychiatric disorder as clinical presentation of primary Sjögren's syndrome: two case reports.

Authors:  Lorenzo Pelizza; Federica Bonacini; Alberto Ferrari
Journal:  Ann Gen Psychiatry       Date:  2010-04-01       Impact factor: 3.455

9.  Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome.

Authors:  Barbara Segal; William Thomas; Tyson Rogers; Joanlise M Leon; Pamela Hughes; Danielle Patel; Ketan Patel; Jill Novitzke; Michael Rohrer; Rajaram Gopalakrishnan; Sandra Myers; Abu Nazmul-Hossain; Eshrat Emamian; Andrew Huang; Nelson Rhodus; Kathy Moser
Journal:  Arthritis Rheum       Date:  2008-12-15

10.  Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United States.

Authors:  Barbara Segal; Simon J Bowman; Philip C Fox; Frederick B Vivino; Nandita Murukutla; Jeff Brodscholl; Sarika Ogale; Lachy McLean
Journal:  Health Qual Life Outcomes       Date:  2009-05-27       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.